- Medical - Diagnostics & Research
- Healthcare
Revvity, Inc.
RVTY · US ·
NYSE
123.485
USD
+3.295
(2.67%)
-
1.51
EPS
-
81.69
P/E
-
15.2B
MARKET CAP
-
0.23%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 1.61 | 4.79 | 3 | 3.53 | 6.69 | 7.3 | 35.24% |
| Avg. Estimate | 1.6 | 4.75 | 2.62 | 3.1 | 6.62 | 7.23 | 35.24% |
| Low Estimate | 1.58 | 4.65 | 1.82 | 2.32 | 6.56 | 7.16 | 35.24% |
| No. Of Analysts | 9 | 13 | 11 | 4 | 2 | 3 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 2.72B | 2.79B | 2.98B | 3.2B | 3.41B | 3.58B | 5.64% |
| Avg. Estimate | 2.71B | 2.78B | 2.96B | 3.18B | 3.38B | 3.55B | 5.56% |
| Low Estimate | 2.69B | 2.77B | 2.94B | 3.15B | 3.36B | 3.52B | 5.56% |
| No. Of Analysts | 11 | 12 | 13 | 10 | 5 | 4 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 201M | 598M | 374M | 441M | 835M | 911M | 35.24% |
| Avg. Estimate | 197M | 593M | 334M | 402M | 827M | 902M | 35.53% |
| Low Estimate | 197M | 581M | 227M | 290M | 818M | 894M | 35.24% |
| No. Of Analysts | 11 | 12 | 13 | 10 | 5 | 4 |